Gyre Therapeutics, Inc.GYRENASDAQ
Loading
ROIC: Returns DecliningContracting
Percentile Rank93
3Y CAGR+10.2%
Studio
Year-over-Year Change

Return on invested capital

3Y CAGR
+10.2%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
20257.74%-33.8%
202411.69%+116.8%
2023-69.52%-1303.2%
20225.78%+103.0%
2021-192.59%-164.2%
2020-72.91%+10.7%
2019-81.66%-190.0%
2018-28.16%+53.4%
2017-60.37%-5.0%
2016-57.47%-